Saturday, October 3, 2026

USD/CNH Went Down By Over 1% In The Last 10 Sessions

ViaNews Editorial Team

January 14, 2024

USD/CNH Went Down By Over 1% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.75% for the last 10 sessions. At 15:07 EST on Sunday, 14 January, USD/CNH (USDCNH) is $7.18.

USD/CNH's yearly highs and lows, it's 0.001% up from its 52-week low and 0.047% down from its 52-week high.

News about

  • Eur/usd tumbles below 1.0950 as middle east tensions escalate, US PPI eyed. According to FXStreet on Friday, 12 January, "The EUR/USD pair has slipped below the crucial support of 1.0950 as the market mood has turned risk-averse amid deepening Middle East tensions. "
  • According to FXStreet on Friday, 12 January, "The EUR/USD kicked off Friday's trading near 1.0980, going back and forth in a rough intraday range as the pair grapples with bids near 1.0950. ", "The challenge will be to drag the EUR/USD down to the last swing low near 1.0750. "
  • Eur/usd recovers slightly amid middle east tensions, post US PPI. According to FXStreet on Friday, 12 January, "Therefore, market participants seeking safety bought Gold and safe-haven peers, which weighed on the EUR/USD in the overnight session.", "From a technical perspective, the EUR/USD is neutral to upward biased, though back-to-back doji's confirm indecision amongst traders. "
  • Eur/usd price analysis: trades higher around 1.0980 on subdued US dollar. According to FXStreet on Friday, 12 January, "This indicates a potential momentum shift towardan upward trend for the EUR/USD pair. ", "A decisive break below the latter could intensify downward pressure on the EUR/USD pair, potentially guiding it toward the 50-day Exponential Moving Average (EMA) at 1.0895 and the 38.2% Fibonacci retracement level at 1.0867. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com